df7551b0e9bd3d3f…

Study
ID: NCT00117403781 bytesFirst seen Jun 12, 20261 collection

Fields

NameValue
briefSummaryThe purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).
completionDate2007-09
conditions["Alzheimer's Disease"]
enrollmentCount75
enrollmentTypeESTIMATED
nctIdNCT00117403
phasePHASE1
sponsorIdnational-institute-on-aging-nia
startDate2006-01
statusCOMPLETED
studyTypeINTERVENTIONAL
titleEvaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease
urlhttps://clinicaltrials.gov/study/NCT00117403

Canonical JSON

{
  "id": "NCT00117403",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).",
    "completionDate": "2007-09",
    "conditions": [
      "Alzheimer's Disease"
    ],
    "enrollmentCount": 75,
    "enrollmentType": "ESTIMATED",
    "nctId": "NCT00117403",
    "phase": "PHASE1",
    "sponsorId": "national-institute-on-aging-nia",
    "startDate": "2006-01",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00117403"
  }
}

Appears in 1 collection

nih/clinical-trials1 version · Jun 12, 2026

Full hash:df7551b0e9bd3d3f6ca464eaebacac75184f2c2ee382fd6880a224aa7b7c1886